GLP-1 Receptor Agonists and Dentistry: Oral Health Implications and Risk Management Considerations
Author: Julie Goldberg, DDS, Senior Dental Risk Specialist
Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly utilized in the management of type 2 diabetes and obesity, resulting in a growing number of dental patients who are prescribed these agents. As their use becomes more widespread, familiarity with the potential oral health implications and procedural considerations associated with GLP-1 therapy may assist dental providers in exercising sound clinical judgment and supporting patient safety.
In March 2026, the American Dental Association incorporated GLP-1–related questions into its health history forms1, prompting practices to consider how this information is collected within their own offices and how these updates may influence existing clinical protocols, policies, and procedures.
Potential Oral Health Considerations Associated With GLP-1 Therapy
GLP-1 receptor agonists work by slowing gastric emptying, increasing satiety, and improving glycemic control. While these effects are often beneficial systemically, they may be associated with oral health changes worth keeping in mind during dental evaluations.
Xerostomia and salivary changes
Some patients using GLP-1 medications report dry mouth, nausea, or reduced oral intake. Xerostomia can contribute to an elevated risk of caries, periodontal inflammation, mucosal irritation, and oral candidiasis. Reduced salivary flow may also lessen buffering capacity, which can be especially relevant for patients experiencing vomiting or gastroesophageal reflux, side effects that are sometimes reported with GLP-1 use.
Nutritional intake and oral manifestations
Significant appetite suppression and rapid weight loss may be associated with nutritional deficiencies in certain patients. Deficiencies in iron, B vitamins, or calcium can present intraorally as glossitis, angular cheilitis, delayed healing, or increased susceptibility to infection following dental procedures.
Diabetes control and periodontal considerations
For patients with diabetes, GLP-1 therapy is often associated with improved glycemic control, which may support periodontal stability over time. However, glucose levels may fluctuate during dose titration or medication changes, and individual responses can vary. Maintaining an individualized, patient-specific assessment remains important.
Patient Education as a Risk Management Tool
Patient education can be a valuable component of preventive risk management when caring for individuals on GLP-1 medications.
Medication history discussions
Dental teams may wish to consider specifically asking about GLP-1 medications during medical history updates, including recent dose changes or side effects. Some patients may not immediately recognize these medications as relevant to dental care unless prompted.
Reinforcing oral hygiene strategies
For patients experiencing xerostomia, discussing enhanced oral hygiene measures may help reduce caries and soft-tissue risk. Options such as increased hydration, saliva substitutes, sugar-free gum containing xylitol, and topical fluoride therapies can be discussed based on individual needs.
Addressing nausea and reflux effects
When patients report nausea or reflux, education about rinsing with water or a neutral solution rather than brushing immediately after emesis may help minimize enamel erosion. In some cases, suggesting they discuss persistent symptoms with their primary care provider or prescribing clinician may be appropriate.
Anesthesia, Sedation, and Procedural Planning Considerations
One area drawing increased attention across healthcare disciplines involves anesthesia and sedation in patients taking GLP-1 medications.
Delayed gastric emptying and aspiration awareness
Because GLP-1 receptor agonists slow gastric emptying, there may be an increased risk of regurgitation and aspiration during procedures involving moderate or deep sedation or general anesthesia. This consideration may be relevant in dental settings where sedation is offered.
Pre-procedure screening and collaboration
During pre-operative assessments, dentists who provide sedation may find it helpful to consider GLP-1 use as part of the overall risk evaluation. In certain cases, coordination with the patient’s prescribing physician can support shared decision-making regarding timing of procedures and medication management.
Sedation planning flexibility
When clinically appropriate, local anesthesia without sedation may be an option worth considering for elective procedures. If sedation is planned, enhanced fasting protocols, heightened airway awareness, and emergency preparedness can serve as additional risk-mitigation strategies.
Documentation and informed discussion
From a risk management standpoint, documenting conversations related to GLP-1 use, potential anesthesia considerations, and treatment alternatives can help demonstrate thoughtful clinical judgment. Incorporating these discussions into the informed consent process may further support clarity and shared understanding.
Closing Perspective: GLP-1 Use in Your Dental Patients
GLP-1 receptor agonists continue to reshape the medical landscape, and their growing use has meaningful intersections with dental care. While many patients experience improved overall health, potential side effects including xerostomia, reflux, nutritional changes, and delayed gastric emptying invite thoughtful consideration in both routine and sedation-related dental care. Dentists who remain informed, engage patients in open dialogue, and tailor care to individual circumstances are well positioned to manage risk while delivering high-quality, patient-centered treatment.
For questions related to dental risk management, contact Dr. Julie Goldberg, Senior Dental Risk Specialist with PMIG: julie.goldberg@pmuw.com
This information is intended to provide general information only on specific risk management topics. It is not intended to provide coverage determinations or coverage positions, nor is it to be construed as legal, medical, or professional advice in any form whatsoever.